Antonio Lanzavecchia

Antonio Lanzavecchia is renowned for his work on antigen presentation processes, T-cell activation, immunological memory, and for his studies on human monoclonal antibodies. He earned his medical degree at the University of Pavia, where he specialized in pediatrics and infectious diseases.

Since 1983, he has worked in Switzerland, initially as a member of the Basel Institute for Immunology and, since 2000, as the founder and director of the Institute for Research in Biomedicine in Bellinzona.

Lanzavecchia has served as Professor of Immunology at the University of Genoa, the University of Siena, and the Swiss Federal Institute of Technology (ETH Zurich).

He is a member of EMBO and the Royal College of Physicians, and an honorary member of the American Society of Immunology, the Swiss Society of Immunology, and the Swiss Academy of Medical Sciences.

He has received the EMBO Gold Medal, the Cloëtta Prize, the Robert Koch Prize, the Sanofi–Institut Pasteur Prize, and the Louis-Jeantet Prize for Medicine.

Lanzavecchia is the scientific founder of Humabs Biomed, now a subsidiary of Vir Biotechnology, and is currently a Senior Researcher at Vir Biotechnology. His academic research activities continue at INGM.